Obesity Clinical Trials in New York

Showing 21-40 of 259 trials

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

NCT07446439

The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.

Nausea and VomitingObesity

Vanda Pharmaceuticals280 participantsStarted Mar 2026

Los Angeles, California, United States • San Diego, California, United States • San Jose, California, United States +7 more locations

RECRUITINGPhase 4< 1 mile

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

PsoriasisOverweight or Obesity

Eli Lilly and Company200 participantsStarted Mar 2025

Phoenix, Arizona, United States • Fountain Valley, California, United States • Fremont, California, United States +40 more locations

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Obesity Trials in Other Cities

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs

Effect of Insulin Lowering on Lipogenesis

Reducing Obesity Using Social Ties Program

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Comparison of Obesity Alleles Among Diverse Demographic Patients

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Other Conditions in New York